

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hypotonic response (GO:0006971) | 9.48652785 |
| 2 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.68815318 |
| 3 | glomerular visceral epithelial cell development (GO:0072015) | 8.10907785 |
| 4 | glomerular basement membrane development (GO:0032836) | 7.20800984 |
| 5 | urate metabolic process (GO:0046415) | 7.16870341 |
| 6 | drug transmembrane transport (GO:0006855) | 6.99609510 |
| 7 | glomerular epithelial cell development (GO:0072310) | 6.91006690 |
| 8 | glomerulus development (GO:0032835) | 5.98822986 |
| 9 | drug transport (GO:0015893) | 5.74916552 |
| 10 | behavioral response to nicotine (GO:0035095) | 5.56302984 |
| 11 | secondary heart field specification (GO:0003139) | 5.56164311 |
| 12 | heart field specification (GO:0003128) | 5.56164311 |
| 13 | cardiac ventricle formation (GO:0003211) | 5.44788034 |
| 14 | organic cation transport (GO:0015695) | 5.39753461 |
| 15 | cellular response to osmotic stress (GO:0071470) | 5.24908392 |
| 16 | hyperosmotic salinity response (GO:0042538) | 5.13630835 |
| 17 | potassium ion homeostasis (GO:0055075) | 5.07351353 |
| 18 | cardiac chamber formation (GO:0003207) | 5.02620774 |
| 19 | metanephric nephron tubule development (GO:0072234) | 4.98194869 |
| 20 | metanephric tubule development (GO:0072170) | 4.98194869 |
| 21 | specification of organ identity (GO:0010092) | 4.79605830 |
| 22 | metanephric epithelium development (GO:0072207) | 4.67687169 |
| 23 | oligosaccharide catabolic process (GO:0009313) | 4.58758977 |
| 24 | glycoside metabolic process (GO:0016137) | 4.52953229 |
| 25 | quaternary ammonium group transport (GO:0015697) | 4.52930467 |
| 26 | metanephric nephron epithelium development (GO:0072243) | 4.44903822 |
| 27 | exogenous drug catabolic process (GO:0042738) | 4.43489967 |
| 28 | lysine metabolic process (GO:0006553) | 4.30502007 |
| 29 | lysine catabolic process (GO:0006554) | 4.30502007 |
| 30 | excretion (GO:0007588) | 4.22560272 |
| 31 | piRNA metabolic process (GO:0034587) | 4.21762099 |
| 32 | phospholipid scrambling (GO:0017121) | 4.19083506 |
| 33 | glyoxylate metabolic process (GO:0046487) | 4.18790999 |
| 34 | centriole replication (GO:0007099) | 4.18067514 |
| 35 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.12878123 |
| 36 | sodium ion homeostasis (GO:0055078) | 4.10429457 |
| 37 | cysteine metabolic process (GO:0006534) | 4.09938797 |
| 38 | response to mercury ion (GO:0046689) | 4.07521791 |
| 39 | phosphate ion transport (GO:0006817) | 4.06877068 |
| 40 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.02027793 |
| 41 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.97599755 |
| 42 | response to thyroid hormone (GO:0097066) | 3.97037751 |
| 43 | response to pheromone (GO:0019236) | 3.91236653 |
| 44 | toxin transport (GO:1901998) | 3.86906268 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.85638440 |
| 46 | nephron epithelium morphogenesis (GO:0072088) | 3.82046619 |
| 47 | nephron tubule morphogenesis (GO:0072078) | 3.82046619 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 3.81364533 |
| 49 | drug catabolic process (GO:0042737) | 3.80167822 |
| 50 | amine catabolic process (GO:0009310) | 3.79220987 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 3.79220987 |
| 52 | fucose catabolic process (GO:0019317) | 3.79174077 |
| 53 | L-fucose metabolic process (GO:0042354) | 3.79174077 |
| 54 | L-fucose catabolic process (GO:0042355) | 3.79174077 |
| 55 | nephron epithelium development (GO:0072009) | 3.78786511 |
| 56 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.77589596 |
| 57 | DNA methylation involved in gamete generation (GO:0043046) | 3.76463026 |
| 58 | nephron tubule development (GO:0072080) | 3.75201182 |
| 59 | DNA deamination (GO:0045006) | 3.72552541 |
| 60 | epithelial cilium movement (GO:0003351) | 3.71323494 |
| 61 | relaxation of smooth muscle (GO:0044557) | 3.68517932 |
| 62 | facial nerve structural organization (GO:0021612) | 3.68341412 |
| 63 | glucosamine-containing compound catabolic process (GO:1901072) | 3.65298514 |
| 64 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.63713143 |
| 65 | proline metabolic process (GO:0006560) | 3.59945383 |
| 66 | trivalent inorganic anion homeostasis (GO:0072506) | 3.47180913 |
| 67 | phosphate ion homeostasis (GO:0055062) | 3.47180913 |
| 68 | lung vasculature development (GO:0060426) | 3.47068427 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 3.44818223 |
| 70 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.44654441 |
| 71 | renal absorption (GO:0070293) | 3.44528873 |
| 72 | positive regulation of neuroblast proliferation (GO:0002052) | 3.42898492 |
| 73 | glutathione biosynthetic process (GO:0006750) | 3.41661644 |
| 74 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.37152353 |
| 75 | ketone body metabolic process (GO:1902224) | 3.36816489 |
| 76 | indole-containing compound catabolic process (GO:0042436) | 3.32640667 |
| 77 | indolalkylamine catabolic process (GO:0046218) | 3.32640667 |
| 78 | tryptophan catabolic process (GO:0006569) | 3.32640667 |
| 79 | kynurenine metabolic process (GO:0070189) | 3.29097564 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 3.28195510 |
| 81 | regulation of axon guidance (GO:1902667) | 3.27705305 |
| 82 | negative regulation of axon guidance (GO:1902668) | 3.25191431 |
| 83 | phosphate ion transmembrane transport (GO:0035435) | 3.22557069 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.20301202 |
| 85 | reciprocal meiotic recombination (GO:0007131) | 3.19255863 |
| 86 | reciprocal DNA recombination (GO:0035825) | 3.19255863 |
| 87 | retinal cone cell development (GO:0046549) | 3.18264007 |
| 88 | sulfate transmembrane transport (GO:1902358) | 3.17913614 |
| 89 | cilium movement (GO:0003341) | 3.16830397 |
| 90 | positive regulation of hormone metabolic process (GO:0032352) | 3.15080630 |
| 91 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.13986152 |
| 92 | detection of light stimulus involved in visual perception (GO:0050908) | 3.13737392 |
| 93 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.13737392 |
| 94 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.13256403 |
| 95 | sphingoid metabolic process (GO:0046519) | 3.11224518 |
| 96 | negative regulation of telomere maintenance (GO:0032205) | 3.10892416 |
| 97 | diol metabolic process (GO:0034311) | 3.10307047 |
| 98 | renal tubule development (GO:0061326) | 3.07923741 |
| 99 | sodium-independent organic anion transport (GO:0043252) | 3.07695951 |
| 100 | glutathione metabolic process (GO:0006749) | 3.07155792 |
| 101 | renal filtration (GO:0097205) | 3.06730828 |
| 102 | rhodopsin mediated signaling pathway (GO:0016056) | 3.05908788 |
| 103 | somite rostral/caudal axis specification (GO:0032525) | 3.05356469 |
| 104 | tonic smooth muscle contraction (GO:0014820) | 3.02853882 |
| 105 | regulation of action potential (GO:0098900) | 3.01587877 |
| 106 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.00551289 |
| 107 | opioid receptor signaling pathway (GO:0038003) | 3.00105325 |
| 108 | response to parathyroid hormone (GO:0071107) | 2.99756791 |
| 109 | tryptophan metabolic process (GO:0006568) | 2.99298589 |
| 110 | negative regulation of metanephros development (GO:0072217) | 2.97433918 |
| 111 | benzene-containing compound metabolic process (GO:0042537) | 2.96601266 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.96022199 |
| 113 | platelet dense granule organization (GO:0060155) | 2.95936925 |
| 114 | histamine transport (GO:0051608) | 2.95145861 |
| 115 | peptide biosynthetic process (GO:0043043) | 2.95039097 |
| 116 | regulation of plasminogen activation (GO:0010755) | 2.94849351 |
| 117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94494988 |
| 118 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.94478022 |
| 119 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.92471134 |
| 120 | inositol metabolic process (GO:0006020) | 2.92233370 |
| 121 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.89843279 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 2.89833517 |
| 123 | carnitine transport (GO:0015879) | 2.89626913 |
| 124 | amino-acid betaine transport (GO:0015838) | 2.89626913 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.89438070 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 2.88274554 |
| 127 | sphingosine metabolic process (GO:0006670) | 2.87470493 |
| 128 | renal tubule morphogenesis (GO:0061333) | 2.87155787 |
| 129 | T-helper 1 type immune response (GO:0042088) | 2.86498328 |
| 130 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.86285716 |
| 131 | water transport (GO:0006833) | 2.85931687 |
| 132 | sulfate transport (GO:0008272) | 2.85106383 |
| 133 | neuronal action potential (GO:0019228) | 2.84688933 |
| 134 | centriole assembly (GO:0098534) | 2.84461889 |
| 135 | neurotransmitter biosynthetic process (GO:0042136) | 2.84079467 |
| 136 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.83989990 |
| 137 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.83699914 |
| 138 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.82963306 |
| 139 | primary amino compound metabolic process (GO:1901160) | 2.82715626 |
| 140 | somite development (GO:0061053) | 2.82253250 |
| 141 | protein-cofactor linkage (GO:0018065) | 2.82194972 |
| 142 | positive regulation of digestive system process (GO:0060456) | 2.81791536 |
| 143 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.81355062 |
| 144 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.79526187 |
| 145 | monoamine transport (GO:0015844) | 2.78086455 |
| 146 | regulation of histone phosphorylation (GO:0033127) | 2.77372669 |
| 147 | axoneme assembly (GO:0035082) | 2.76433755 |
| 148 | central nervous system myelination (GO:0022010) | 2.75169912 |
| 149 | axon ensheathment in central nervous system (GO:0032291) | 2.75169912 |
| 150 | positive regulation of action potential (GO:0045760) | 2.72001791 |
| 151 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.71917975 |
| 152 | ganglion development (GO:0061548) | 2.71760234 |
| 153 | glomerular filtration (GO:0003094) | 2.71594754 |
| 154 | response to salt stress (GO:0009651) | 2.71339294 |
| 155 | regulation of mesoderm development (GO:2000380) | 2.70489458 |
| 156 | indole-containing compound metabolic process (GO:0042430) | 2.70462761 |
| 157 | cGMP-mediated signaling (GO:0019934) | 2.70354248 |
| 158 | branched-chain amino acid metabolic process (GO:0009081) | 2.70119689 |
| 159 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.69618315 |
| 160 | NADH dehydrogenase complex assembly (GO:0010257) | 2.69618315 |
| 161 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.69618315 |
| 162 | hindbrain development (GO:0030902) | 2.69226945 |
| 163 | mannosylation (GO:0097502) | 2.69117531 |
| 164 | meiotic chromosome segregation (GO:0045132) | 2.67729308 |
| 165 | multicellular organism reproduction (GO:0032504) | 2.67715187 |
| 166 | synaptic transmission, cholinergic (GO:0007271) | 2.67535744 |
| 167 | cornea development in camera-type eye (GO:0061303) | 2.67260703 |
| 168 | serotonin metabolic process (GO:0042428) | 2.65557644 |
| 169 | neuron fate determination (GO:0048664) | 2.65072355 |
| 170 | xenobiotic catabolic process (GO:0042178) | 2.64569859 |
| 171 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.63106020 |
| 172 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.62425443 |
| 173 | reflex (GO:0060004) | 2.61421576 |
| 174 | behavioral response to ethanol (GO:0048149) | 2.61375679 |
| 175 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.60279275 |
| 176 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.60279275 |
| 177 | protein complex biogenesis (GO:0070271) | 2.57128696 |
| 178 | cAMP catabolic process (GO:0006198) | 2.56204425 |
| 179 | axonemal dynein complex assembly (GO:0070286) | 2.54557263 |
| 180 | response to nitrosative stress (GO:0051409) | 2.54014971 |
| 181 | regulation of hippo signaling (GO:0035330) | 2.53838357 |
| 182 | nonmotile primary cilium assembly (GO:0035058) | 2.53806611 |
| 183 | regulation of meiosis I (GO:0060631) | 2.53260912 |
| 184 | photoreceptor cell development (GO:0042461) | 2.53243095 |
| 185 | positive regulation of meiosis (GO:0045836) | 2.53205067 |
| 186 | cilium organization (GO:0044782) | 2.53143351 |
| 187 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.52408954 |
| 188 | kidney morphogenesis (GO:0060993) | 2.51395225 |
| 189 | positive regulation of defense response to virus by host (GO:0002230) | 2.50601181 |
| 190 | negative regulation of mast cell activation (GO:0033004) | 2.50121335 |
| 191 | parturition (GO:0007567) | 2.49245173 |
| 192 | protein-chromophore linkage (GO:0018298) | 2.48369047 |
| 193 | male meiosis I (GO:0007141) | 2.47346857 |
| 194 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45708509 |
| 195 | positive regulation of meiotic cell cycle (GO:0051446) | 2.44922872 |
| 196 | neural tube formation (GO:0001841) | 2.44205505 |
| 197 | positive regulation of fatty acid transport (GO:2000193) | 2.43585564 |
| 198 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.41947265 |
| 199 | one-carbon compound transport (GO:0019755) | 11.2871544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.78153255 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.52891566 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.32840249 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.02353839 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.61644681 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.36608116 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.16607086 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.12964214 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.01615165 |
| 10 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.76459541 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.72481462 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41893224 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.38024873 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31370761 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23418746 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.22623838 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.16688786 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.11501982 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11441078 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.00707531 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98243058 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97882033 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97369483 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88814842 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87817185 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81939637 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80511130 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.79527456 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78767773 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78671849 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78235187 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.73335907 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.73068219 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72973937 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72285731 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72006459 |
| 37 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.68980324 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68729963 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67325446 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64499699 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63692051 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.62165045 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61455445 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.57891234 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57264154 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.57149852 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56844453 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56265364 |
| 49 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.54702497 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.54702497 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52151321 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51011930 |
| 53 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.48989125 |
| 54 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.48989125 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48866192 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47428289 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46755241 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44848813 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.44837673 |
| 60 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44837673 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.43096729 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40751534 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40098345 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39776278 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39162842 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38468344 |
| 67 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.38235393 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37988639 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.37439747 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34988428 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34903282 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33780678 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.33687940 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32956759 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32081447 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31720090 |
| 77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31332656 |
| 78 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30586919 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29829782 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29230437 |
| 81 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29230437 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27822534 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27471389 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.26758635 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26708140 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26629042 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26385460 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26385460 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26119886 |
| 90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25428043 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25342832 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25211645 |
| 93 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24423287 |
| 94 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.23760528 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23068707 |
| 96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21479961 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 1.21419930 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.19966298 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19444869 |
| 100 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19270441 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18786270 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18502256 |
| 103 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17357261 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16724348 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14222729 |
| 106 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.13914980 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13338941 |
| 108 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13155199 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11346139 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11020653 |
| 111 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.10175923 |
| 112 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10011835 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09800054 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08795864 |
| 115 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08382546 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07716020 |
| 117 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.07627434 |
| 118 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07384156 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06217551 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03623559 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03312132 |
| 122 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02384204 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01370724 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00971947 |
| 125 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00792211 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00324220 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00263270 |
| 128 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00101360 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99567581 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99184562 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.98639787 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98083641 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97989928 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97798647 |
| 135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97717538 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96958808 |
| 137 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96861978 |
| 138 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96677976 |
| 139 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96547698 |
| 140 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.96535038 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95275189 |
| 142 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94115407 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93743660 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92559913 |
| 145 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92422444 |
| 146 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90510206 |
| 147 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88642991 |
| 148 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88564410 |
| 149 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88043360 |
| 150 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87180341 |
| 151 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85659821 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85064507 |
| 153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85025516 |
| 154 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.84930742 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84576138 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82176672 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80625052 |
| 158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80410750 |
| 159 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80067593 |
| 160 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79698991 |
| 161 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78604576 |
| 162 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78548296 |
| 163 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77885415 |
| 164 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77842230 |
| 165 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.76484705 |
| 166 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76046050 |
| 167 | JUN_21703547_ChIP-Seq_K562_Human | 0.75930176 |
| 168 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75767066 |
| 169 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.75227332 |
| 170 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.74509828 |
| 171 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.71931458 |
| 172 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71669249 |
| 173 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70996225 |
| 174 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.70516109 |
| 175 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70451728 |
| 176 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69802362 |
| 177 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69630844 |
| 178 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.69153317 |
| 179 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.68115614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 9.18432951 |
| 2 | MP0005367_renal/urinary_system_phenotyp | 8.87874011 |
| 3 | MP0000516_abnormal_urinary_system | 8.87874011 |
| 4 | MP0003136_yellow_coat_color | 5.04939600 |
| 5 | MP0001756_abnormal_urination | 3.46537112 |
| 6 | MP0000534_abnormal_ureter_morphology | 3.31155962 |
| 7 | MP0005332_abnormal_amino_acid | 3.28333565 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.03109877 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.90926773 |
| 10 | MP0009643_abnormal_urine_homeostasis | 2.62168121 |
| 11 | MP0005360_urolithiasis | 2.61760700 |
| 12 | MP0003011_delayed_dark_adaptation | 2.40452614 |
| 13 | MP0002102_abnormal_ear_morphology | 2.36423084 |
| 14 | MP0001958_emphysema | 2.32449396 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.22185167 |
| 16 | MP0002136_abnormal_kidney_physiology | 2.21278246 |
| 17 | MP0002938_white_spotting | 2.12144641 |
| 18 | MP0003283_abnormal_digestive_organ | 2.08937352 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.08547392 |
| 20 | MP0003878_abnormal_ear_physiology | 1.92966804 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 1.92966804 |
| 22 | MP0006054_spinal_hemorrhage | 1.90799199 |
| 23 | MP0005171_absent_coat_pigmentation | 1.90291825 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.90118678 |
| 25 | MP0002736_abnormal_nociception_after | 1.84869033 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.84438164 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.83932349 |
| 28 | MP0000230_abnormal_systemic_arterial | 1.83897611 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.83721982 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.80001777 |
| 31 | MP0004142_abnormal_muscle_tone | 1.78518337 |
| 32 | MP0009745_abnormal_behavioral_response | 1.78197954 |
| 33 | MP0000566_synostosis | 1.74516127 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.73703561 |
| 35 | MP0002272_abnormal_nervous_system | 1.72624077 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.72353977 |
| 37 | MP0008872_abnormal_physiological_respon | 1.71390797 |
| 38 | MP0004043_abnormal_pH_regulation | 1.64880143 |
| 39 | MP0005253_abnormal_eye_physiology | 1.64833912 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.60583592 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.60290608 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.57645803 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.56049190 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.54859707 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.50767310 |
| 46 | MP0004742_abnormal_vestibular_system | 1.49763082 |
| 47 | MP0001664_abnormal_digestion | 1.49042089 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.48798727 |
| 49 | MP0004147_increased_porphyrin_level | 1.46507883 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.45595665 |
| 51 | MP0001486_abnormal_startle_reflex | 1.45187416 |
| 52 | MP0009046_muscle_twitch | 1.44896415 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43271751 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.43045768 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.36993855 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.35912069 |
| 57 | MP0002135_abnormal_kidney_morphology | 1.34775033 |
| 58 | MP0000427_abnormal_hair_cycle | 1.32067252 |
| 59 | MP0003315_abnormal_perineum_morphology | 1.31270906 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.30445767 |
| 61 | MP0003880_abnormal_central_pattern | 1.27078176 |
| 62 | MP0002064_seizures | 1.24279031 |
| 63 | MP0002160_abnormal_reproductive_system | 1.23801993 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.22984021 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 1.21132029 |
| 66 | MP0000026_abnormal_inner_ear | 1.20206792 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.17830949 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.15350902 |
| 69 | MP0001905_abnormal_dopamine_level | 1.13934314 |
| 70 | MP0004885_abnormal_endolymph | 1.12836630 |
| 71 | MP0001984_abnormal_olfaction | 1.10950760 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.06041232 |
| 73 | MP0001970_abnormal_pain_threshold | 1.05995699 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.05521281 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.04974699 |
| 76 | MP0003866_abnormal_defecation | 1.04224859 |
| 77 | MP0002163_abnormal_gland_morphology | 1.04070503 |
| 78 | MP0003137_abnormal_impulse_conducting | 1.02011384 |
| 79 | MP0005423_abnormal_somatic_nervous | 1.01474279 |
| 80 | MP0003938_abnormal_ear_development | 1.01113286 |
| 81 | MP0002009_preneoplasia | 1.00944304 |
| 82 | MP0004381_abnormal_hair_follicle | 1.00368573 |
| 83 | MP0005365_abnormal_bile_salt | 0.99842907 |
| 84 | MP0004133_heterotaxia | 0.99529523 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.99364920 |
| 86 | MP0002557_abnormal_social/conspecific_i | 0.98679990 |
| 87 | MP0005389_reproductive_system_phenotype | 0.97841277 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.94878991 |
| 89 | MP0002063_abnormal_learning/memory/cond | 0.93715316 |
| 90 | MP0003252_abnormal_bile_duct | 0.93408157 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.92795313 |
| 92 | MP0000751_myopathy | 0.92699701 |
| 93 | MP0004272_abnormal_basement_membrane | 0.90205555 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.90149107 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.90038018 |
| 96 | MP0004924_abnormal_behavior | 0.90038018 |
| 97 | MP0005409_darkened_coat_color | 0.90006725 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.89613610 |
| 99 | MP0005410_abnormal_fertilization | 0.88100991 |
| 100 | MP0003045_fibrosis | 0.87765519 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.87669482 |
| 102 | MP0002796_impaired_skin_barrier | 0.87414259 |
| 103 | MP0005195_abnormal_posterior_eye | 0.87326103 |
| 104 | MP0003635_abnormal_synaptic_transmissio | 0.86529174 |
| 105 | MP0000462_abnormal_digestive_system | 0.84925611 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.83717944 |
| 107 | MP0001879_abnormal_lymphatic_vessel | 0.83478451 |
| 108 | MP0003941_abnormal_skin_development | 0.81095381 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.80993555 |
| 110 | MP0003724_increased_susceptibility_to | 0.80618113 |
| 111 | MP0002229_neurodegeneration | 0.79468754 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.78509095 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.77504660 |
| 114 | MP0001324_abnormal_eye_pigmentation | 0.77328410 |
| 115 | MP0002396_abnormal_hematopoietic_system | 0.77079342 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.76755366 |
| 117 | MP0000343_altered_response_to | 0.76183107 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.74717562 |
| 119 | MP0001529_abnormal_vocalization | 0.74213443 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.74025589 |
| 121 | MP0005083_abnormal_biliary_tract | 0.73675760 |
| 122 | MP0003698_abnormal_male_reproductive | 0.73541755 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.73443556 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.72807750 |
| 125 | MP0000778_abnormal_nervous_system | 0.72794129 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.72772763 |
| 127 | MP0001270_distended_abdomen | 0.72334527 |
| 128 | MP0003646_muscle_fatigue | 0.72279044 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.71560625 |
| 130 | MP0003943_abnormal_hepatobiliary_system | 0.71351060 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.70697485 |
| 132 | MP0010155_abnormal_intestine_physiology | 0.68218068 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.68140468 |
| 134 | MP0000537_abnormal_urethra_morphology | 0.65142566 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.63730919 |
| 136 | MP0005595_abnormal_vascular_smooth | 0.63595271 |
| 137 | MP0003186_abnormal_redox_activity | 0.62689353 |
| 138 | MP0001663_abnormal_digestive_system | 0.62654355 |
| 139 | MP0000383_abnormal_hair_follicle | 0.62592246 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.62504501 |
| 141 | MP0005165_increased_susceptibility_to | 0.62246417 |
| 142 | MP0000467_abnormal_esophagus_morphology | 0.61992785 |
| 143 | MP0002928_abnormal_bile_duct | 0.61275746 |
| 144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60052964 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.59118166 |
| 146 | MP0005197_abnormal_uvea_morphology | 0.57707928 |
| 147 | MP0005085_abnormal_gallbladder_physiolo | 0.55540989 |
| 148 | MP0000477_abnormal_intestine_morphology | 0.53455877 |
| 149 | MP0000678_abnormal_parathyroid_gland | 0.50566290 |
| 150 | MP0002098_abnormal_vibrissa_morphology | 0.50469210 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.50421295 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.49049104 |
| 153 | MP0005503_abnormal_tendon_morphology | 0.48049512 |
| 154 | MP0005501_abnormal_skin_physiology | 0.47956195 |
| 155 | MP0009379_abnormal_foot_pigmentation | 0.46786087 |
| 156 | MP0005330_cardiomyopathy | 0.46770522 |
| 157 | MP0008775_abnormal_heart_ventricle | 0.45266445 |
| 158 | MP0001835_abnormal_antigen_presentation | 0.43805067 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.43665274 |
| 160 | MP0009053_abnormal_anal_canal | 0.42742853 |
| 161 | MP0005464_abnormal_platelet_physiology | 0.42449711 |
| 162 | MP0009764_decreased_sensitivity_to | 0.41989722 |
| 163 | MP0006036_abnormal_mitochondrial_physio | 0.41349714 |
| 164 | MP0005187_abnormal_penis_morphology | 0.39184649 |
| 165 | MP0003879_abnormal_hair_cell | 0.38812924 |
| 166 | MP0001731_abnormal_postnatal_growth | 0.38159168 |
| 167 | MP0008469_abnormal_protein_level | 0.37365701 |
| 168 | MP0003195_calcinosis | 0.37301467 |
| 169 | MP0003942_abnormal_urinary_system | 0.37077675 |
| 170 | MP0003718_maternal_effect | 0.35875440 |
| 171 | MP0009642_abnormal_blood_homeostasis | 0.35673355 |
| 172 | MP0010678_abnormal_skin_adnexa | 0.35023262 |
| 173 | MP0005174_abnormal_tail_pigmentation | 0.34671883 |
| 174 | MP0003937_abnormal_limbs/digits/tail_de | 0.34287608 |
| 175 | MP0002092_abnormal_eye_morphology | 0.34014559 |
| 176 | MP0005166_decreased_susceptibility_to | 0.33321041 |
| 177 | MP0003828_pulmonary_edema | 0.33055581 |
| 178 | MP0001915_intracranial_hemorrhage | 0.32267995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aortic aneurysm (HP:0004942) | 7.46782759 |
| 2 | Type II lissencephaly (HP:0007260) | 5.16782131 |
| 3 | Malnutrition (HP:0004395) | 5.12813679 |
| 4 | Hypomagnesemia (HP:0002917) | 5.12386739 |
| 5 | Aortic dissection (HP:0002647) | 4.52411587 |
| 6 | Cerebellar dysplasia (HP:0007033) | 4.50418490 |
| 7 | Abnormal pupillary function (HP:0007686) | 4.41462486 |
| 8 | Pancreatic cysts (HP:0001737) | 4.38962506 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 4.16628422 |
| 10 | Hypoplasia of the pons (HP:0012110) | 3.91270152 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.89254516 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.89254516 |
| 13 | Abnormality of the pons (HP:0007361) | 3.89077801 |
| 14 | Ankle contracture (HP:0006466) | 3.79443581 |
| 15 | Gastrointestinal dysmotility (HP:0002579) | 3.78027567 |
| 16 | Retinal dysplasia (HP:0007973) | 3.72670718 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.72529417 |
| 18 | Hypokalemic alkalosis (HP:0001949) | 3.68481438 |
| 19 | Facial diplegia (HP:0001349) | 3.68069297 |
| 20 | Nephronophthisis (HP:0000090) | 3.64222585 |
| 21 | True hermaphroditism (HP:0010459) | 3.62215788 |
| 22 | Increased circulating renin level (HP:0000848) | 3.61300715 |
| 23 | Persistence of primary teeth (HP:0006335) | 3.56808512 |
| 24 | Congenital stationary night blindness (HP:0007642) | 3.44969431 |
| 25 | Reticulocytopenia (HP:0001896) | 3.28379374 |
| 26 | Abnormality of the renal medulla (HP:0100957) | 3.28122809 |
| 27 | Metabolic alkalosis (HP:0200114) | 3.25190115 |
| 28 | Gout (HP:0001997) | 3.25161990 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.24239504 |
| 30 | Abnormality of chloride homeostasis (HP:0011422) | 3.21959348 |
| 31 | Neoplasm of the heart (HP:0100544) | 3.21219535 |
| 32 | Abnormal foot bone ossification (HP:0010675) | 3.14149711 |
| 33 | Mesangial abnormality (HP:0001966) | 3.11520541 |
| 34 | Tetany (HP:0001281) | 3.11269236 |
| 35 | Focal segmental glomerulosclerosis (HP:0000097) | 3.06646060 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.05738285 |
| 37 | Metaphyseal dysplasia (HP:0100255) | 3.04529603 |
| 38 | Polyuria (HP:0000103) | 3.04098933 |
| 39 | Medial flaring of the eyebrow (HP:0010747) | 3.03495621 |
| 40 | Broad distal phalanx of finger (HP:0009836) | 3.00657858 |
| 41 | Focal motor seizures (HP:0011153) | 2.99745999 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.92262845 |
| 43 | Cystic liver disease (HP:0006706) | 2.86691421 |
| 44 | Absent/shortened dynein arms (HP:0200106) | 2.86107184 |
| 45 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.86107184 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.84875651 |
| 47 | Stridor (HP:0010307) | 2.83248634 |
| 48 | Abnormality of abdominal situs (HP:0011620) | 2.82484056 |
| 49 | Abdominal situs inversus (HP:0003363) | 2.82484056 |
| 50 | Retinal atrophy (HP:0001105) | 2.80403826 |
| 51 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.77651696 |
| 52 | Spastic diplegia (HP:0001264) | 2.76358530 |
| 53 | Abnormal urine output (HP:0012590) | 2.74931641 |
| 54 | Hypercalciuria (HP:0002150) | 2.74053166 |
| 55 | Large for gestational age (HP:0001520) | 2.72697877 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.72566223 |
| 57 | Broad face (HP:0000283) | 2.72172000 |
| 58 | Glomerulosclerosis (HP:0000096) | 2.71441325 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.70452719 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.69894603 |
| 61 | Knee flexion contracture (HP:0006380) | 2.68923006 |
| 62 | Abnormality of renal excretion (HP:0011036) | 2.68792566 |
| 63 | Abnormal ossification of hand bones (HP:0005921) | 2.68176059 |
| 64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.68054399 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.68054399 |
| 66 | Hyperglycinemia (HP:0002154) | 2.66425760 |
| 67 | Hyperglycinuria (HP:0003108) | 2.60033914 |
| 68 | Tubular atrophy (HP:0000092) | 2.59510824 |
| 69 | Amelogenesis imperfecta (HP:0000705) | 2.57933190 |
| 70 | Abnormality of carpal bone ossification (HP:0006257) | 2.55805681 |
| 71 | Radial bowing (HP:0002986) | 2.55493178 |
| 72 | Abnormal drinking behavior (HP:0030082) | 2.54755236 |
| 73 | Polydipsia (HP:0001959) | 2.54755236 |
| 74 | Progressive inability to walk (HP:0002505) | 2.53271787 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.52908101 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 2.51866394 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.48684852 |
| 78 | Aplastic anemia (HP:0001915) | 2.48194455 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 2.46539408 |
| 80 | Hemangiomatosis (HP:0007461) | 2.44575765 |
| 81 | Lissencephaly (HP:0001339) | 2.42903772 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.42708091 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.42054012 |
| 84 | Inability to walk (HP:0002540) | 2.42030214 |
| 85 | Concave nail (HP:0001598) | 2.40489535 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.39955604 |
| 87 | Sclerocornea (HP:0000647) | 2.39608485 |
| 88 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.38073790 |
| 89 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.38073790 |
| 90 | Methylmalonic aciduria (HP:0012120) | 2.33931424 |
| 91 | Abnormality of the 2nd finger (HP:0004100) | 2.32648510 |
| 92 | Hydroureter (HP:0000072) | 2.31605249 |
| 93 | Increased purine levels (HP:0004368) | 2.30797968 |
| 94 | Hyperuricemia (HP:0002149) | 2.30797968 |
| 95 | Metaphyseal cupping (HP:0003021) | 2.30668006 |
| 96 | Chronic hepatic failure (HP:0100626) | 2.30571897 |
| 97 | Gait imbalance (HP:0002141) | 2.29953786 |
| 98 | Parakeratosis (HP:0001036) | 2.27926479 |
| 99 | Pendular nystagmus (HP:0012043) | 2.26623684 |
| 100 | Abnormal ciliary motility (HP:0012262) | 2.26248342 |
| 101 | Glycosuria (HP:0003076) | 2.25951779 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.25951779 |
| 103 | Hepatocellular necrosis (HP:0001404) | 2.25623684 |
| 104 | Hyperventilation (HP:0002883) | 2.24666298 |
| 105 | Increased density of long bones (HP:0006392) | 2.24098454 |
| 106 | Congenital hepatic fibrosis (HP:0002612) | 2.23973617 |
| 107 | Abnormal number of erythroid precursors (HP:0012131) | 2.23470059 |
| 108 | Nonprogressive disorder (HP:0003680) | 2.23364083 |
| 109 | Severe muscular hypotonia (HP:0006829) | 2.22299504 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.22138564 |
| 111 | Ulnar bowing (HP:0003031) | 2.17819456 |
| 112 | Attenuation of retinal blood vessels (HP:0007843) | 2.16575081 |
| 113 | Optic nerve hypoplasia (HP:0000609) | 2.16180590 |
| 114 | Capillary hemangiomas (HP:0005306) | 2.14875475 |
| 115 | Ketosis (HP:0001946) | 2.12445373 |
| 116 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12352066 |
| 117 | Flared metaphyses (HP:0003015) | 2.12086719 |
| 118 | Hypophosphatemia (HP:0002148) | 2.11862845 |
| 119 | Absent frontal sinuses (HP:0002688) | 2.10663680 |
| 120 | Delayed epiphyseal ossification (HP:0002663) | 2.10364186 |
| 121 | Hydroxyprolinuria (HP:0003080) | 2.10244984 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 2.10244984 |
| 123 | Congenital primary aphakia (HP:0007707) | 2.10019899 |
| 124 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.09082248 |
| 125 | Alkalosis (HP:0001948) | 2.08943116 |
| 126 | Hyperaldosteronism (HP:0000859) | 2.08446821 |
| 127 | Furrowed tongue (HP:0000221) | 2.05947985 |
| 128 | IgG deficiency (HP:0004315) | 2.05103285 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04915596 |
| 130 | Elbow flexion contracture (HP:0002987) | 2.04762151 |
| 131 | Hip contracture (HP:0003273) | 2.03718065 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.03668644 |
| 133 | Conical tooth (HP:0000698) | 2.02790293 |
| 134 | Dialeptic seizures (HP:0011146) | 2.02765664 |
| 135 | Stage 5 chronic kidney disease (HP:0003774) | 2.02248405 |
| 136 | Ureteral stenosis (HP:0000071) | 2.02136276 |
| 137 | Abnormality of renin-angiotensin system (HP:0000847) | 1.99152193 |
| 138 | Increased corneal curvature (HP:0100692) | 1.98789704 |
| 139 | Keratoconus (HP:0000563) | 1.98789704 |
| 140 | Stomach cancer (HP:0012126) | 1.98772360 |
| 141 | Aplasia of the musculature (HP:0100854) | 1.98397719 |
| 142 | Renal tubular acidosis (HP:0001947) | 1.98245694 |
| 143 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.97872262 |
| 144 | Non-midline cleft lip (HP:0100335) | 1.96170129 |
| 145 | Hepatic necrosis (HP:0002605) | 1.95508757 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94980900 |
| 147 | Abnormality of alanine metabolism (HP:0010916) | 1.93324078 |
| 148 | Hyperalaninemia (HP:0003348) | 1.93324078 |
| 149 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93324078 |
| 150 | Renal cortical cysts (HP:0000803) | 1.92662084 |
| 151 | Progressive cerebellar ataxia (HP:0002073) | 1.91712186 |
| 152 | Hyperparathyroidism (HP:0000843) | 1.91488414 |
| 153 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90246341 |
| 154 | Pancytopenia (HP:0001876) | 1.90207945 |
| 155 | Renal salt wasting (HP:0000127) | 1.90159031 |
| 156 | Anencephaly (HP:0002323) | 1.90130234 |
| 157 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89258565 |
| 158 | Hypoalbuminemia (HP:0003073) | 1.89097374 |
| 159 | Abnormal albumin level (HP:0012116) | 1.89097374 |
| 160 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.88342008 |
| 161 | Bicuspid aortic valve (HP:0001647) | 1.87772750 |
| 162 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.87054206 |
| 163 | Ulnar claw (HP:0001178) | 1.86474636 |
| 164 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.86001888 |
| 165 | Tubulointerstitial fibrosis (HP:0005576) | 1.85910370 |
| 166 | Postaxial foot polydactyly (HP:0001830) | 1.85832294 |
| 167 | Bowing of the arm (HP:0006488) | 1.85716038 |
| 168 | Bowed forearm bones (HP:0003956) | 1.85716038 |
| 169 | Neonatal onset (HP:0003623) | 1.85444324 |
| 170 | Pachygyria (HP:0001302) | 1.84835628 |
| 171 | Gaze-evoked nystagmus (HP:0000640) | 1.83743164 |
| 172 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83742299 |
| 173 | Bilateral microphthalmos (HP:0007633) | 1.83715924 |
| 174 | Abnormality of the vitreous humor (HP:0004327) | 1.80585080 |
| 175 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77844429 |
| 176 | Genital tract atresia (HP:0001827) | 1.77747497 |
| 177 | Hypothermia (HP:0002045) | 1.77457120 |
| 178 | Septo-optic dysplasia (HP:0100842) | 1.76330970 |
| 179 | Clumsiness (HP:0002312) | 1.76189470 |
| 180 | Colon cancer (HP:0003003) | 1.75895586 |
| 181 | Vaginal atresia (HP:0000148) | 1.75737198 |
| 182 | Absent thumb (HP:0009777) | 1.75381164 |
| 183 | Anterior segment dysgenesis (HP:0007700) | 1.75183802 |
| 184 | Chorioretinal atrophy (HP:0000533) | 1.74527819 |
| 185 | Patellar aplasia (HP:0006443) | 1.72820731 |
| 186 | Tubulointerstitial abnormality (HP:0001969) | 1.71918718 |
| 187 | Hemiparesis (HP:0001269) | 1.70950352 |
| 188 | Male pseudohermaphroditism (HP:0000037) | 1.70259519 |
| 189 | Genetic anticipation (HP:0003743) | 1.68984163 |
| 190 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68385259 |
| 191 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.68378723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 7.08708585 |
| 2 | TTN | 6.76095170 |
| 3 | WNK4 | 4.27668490 |
| 4 | FRK | 3.80481894 |
| 5 | OXSR1 | 3.07466178 |
| 6 | ZAK | 2.67893297 |
| 7 | TXK | 2.60175073 |
| 8 | WNK1 | 2.59345133 |
| 9 | ACVR1B | 2.59133349 |
| 10 | TNIK | 2.57392637 |
| 11 | ADRBK2 | 2.52999426 |
| 12 | TGFBR1 | 2.30422991 |
| 13 | MAPK15 | 2.27931327 |
| 14 | TAOK3 | 2.25275733 |
| 15 | TLK1 | 2.15165601 |
| 16 | EPHB2 | 2.05762163 |
| 17 | WNK3 | 2.02810125 |
| 18 | STK39 | 1.95762827 |
| 19 | PIK3CG | 1.95409248 |
| 20 | NEK1 | 1.93563468 |
| 21 | PAK2 | 1.89975857 |
| 22 | INSRR | 1.87654724 |
| 23 | GRK1 | 1.86923852 |
| 24 | BCKDK | 1.80989163 |
| 25 | BMPR1B | 1.76791506 |
| 26 | EPHA3 | 1.76730448 |
| 27 | MAP3K13 | 1.75917240 |
| 28 | MAP2K2 | 1.71097350 |
| 29 | DMPK | 1.64367066 |
| 30 | TSSK6 | 1.63835449 |
| 31 | MAPK13 | 1.55344207 |
| 32 | MAP4K2 | 1.51025010 |
| 33 | DAPK2 | 1.43863118 |
| 34 | EPHB1 | 1.42172476 |
| 35 | WEE1 | 1.42088274 |
| 36 | TGFBR2 | 1.42047922 |
| 37 | NUAK1 | 1.40491634 |
| 38 | PINK1 | 1.39582187 |
| 39 | LATS2 | 1.31523568 |
| 40 | MST1R | 1.27172571 |
| 41 | MUSK | 1.21241759 |
| 42 | DYRK2 | 1.20431220 |
| 43 | VRK1 | 1.19469934 |
| 44 | CDK19 | 1.14670690 |
| 45 | NTRK2 | 1.14466061 |
| 46 | PBK | 1.12112645 |
| 47 | MINK1 | 1.11361690 |
| 48 | ARAF | 1.10987637 |
| 49 | CDC7 | 1.10547341 |
| 50 | MATK | 1.08180107 |
| 51 | MARK1 | 1.07889324 |
| 52 | MKNK1 | 1.05415243 |
| 53 | PNCK | 1.02919388 |
| 54 | STK38 | 1.00770244 |
| 55 | CAMK2G | 0.99918630 |
| 56 | MARK3 | 0.97094313 |
| 57 | NME1 | 0.95700020 |
| 58 | STK11 | 0.89756856 |
| 59 | TAF1 | 0.87434284 |
| 60 | PRKCG | 0.85927501 |
| 61 | PTK2B | 0.84295686 |
| 62 | TEC | 0.81834515 |
| 63 | GRK5 | 0.81099094 |
| 64 | PHKG2 | 0.80685280 |
| 65 | PHKG1 | 0.80685280 |
| 66 | MAP3K12 | 0.80551233 |
| 67 | PRKD3 | 0.80384446 |
| 68 | VRK2 | 0.77501049 |
| 69 | RPS6KA6 | 0.76822285 |
| 70 | PAK3 | 0.76716602 |
| 71 | NTRK3 | 0.76152187 |
| 72 | PIK3CA | 0.75796630 |
| 73 | MAPKAPK5 | 0.74860024 |
| 74 | IKBKB | 0.74379740 |
| 75 | STK3 | 0.73469988 |
| 76 | NLK | 0.73271113 |
| 77 | CAMK1 | 0.72318300 |
| 78 | PRKCE | 0.71597277 |
| 79 | MAPKAPK3 | 0.70689120 |
| 80 | PASK | 0.70394715 |
| 81 | CHUK | 0.68875368 |
| 82 | BCR | 0.67721237 |
| 83 | DYRK3 | 0.67086557 |
| 84 | MAP3K4 | 0.66586828 |
| 85 | MELK | 0.66134156 |
| 86 | CDC42BPA | 0.65646813 |
| 87 | CCNB1 | 0.65207467 |
| 88 | MAP2K7 | 0.64921528 |
| 89 | PRKD2 | 0.63499025 |
| 90 | CAMK2B | 0.61878919 |
| 91 | PRKCH | 0.60878801 |
| 92 | FGFR4 | 0.59307880 |
| 93 | MST4 | 0.59020082 |
| 94 | BTK | 0.58209398 |
| 95 | NEK2 | 0.58068418 |
| 96 | KIT | 0.58044920 |
| 97 | PAK1 | 0.57785058 |
| 98 | RPS6KA2 | 0.56955782 |
| 99 | BRSK2 | 0.56836550 |
| 100 | GSK3A | 0.56615766 |
| 101 | CDK8 | 0.55618588 |
| 102 | MAP3K14 | 0.55618121 |
| 103 | STK10 | 0.55028263 |
| 104 | PRKACB | 0.52749655 |
| 105 | PIM1 | 0.51473717 |
| 106 | TRIM28 | 0.51229490 |
| 107 | AKT3 | 0.49418510 |
| 108 | TYRO3 | 0.48028340 |
| 109 | EPHA4 | 0.46853475 |
| 110 | FER | 0.46698152 |
| 111 | GRK7 | 0.44286465 |
| 112 | MAPK4 | 0.43456278 |
| 113 | PKN1 | 0.41964756 |
| 114 | CDK3 | 0.41914118 |
| 115 | STK38L | 0.41427402 |
| 116 | ALK | 0.40654862 |
| 117 | LATS1 | 0.40561950 |
| 118 | RAF1 | 0.40255959 |
| 119 | FGFR2 | 0.38476776 |
| 120 | STK16 | 0.38376842 |
| 121 | PRKACA | 0.38353081 |
| 122 | RPS6KA5 | 0.38275404 |
| 123 | PRKCQ | 0.38221585 |
| 124 | CAMK2A | 0.37994135 |
| 125 | MAP3K7 | 0.34449454 |
| 126 | FLT3 | 0.33852848 |
| 127 | LIMK1 | 0.33346111 |
| 128 | PIM2 | 0.32736783 |
| 129 | IRAK3 | 0.32717426 |
| 130 | OBSCN | 0.32641129 |
| 131 | TIE1 | 0.32599245 |
| 132 | PRKCI | 0.32133019 |
| 133 | PDK2 | 0.32101946 |
| 134 | PAK4 | 0.31900986 |
| 135 | ROCK2 | 0.31727329 |
| 136 | ERBB2 | 0.30286858 |
| 137 | CSNK1D | 0.29408262 |
| 138 | MAP2K6 | 0.28989646 |
| 139 | PDK1 | 0.28534697 |
| 140 | MAP2K1 | 0.28521354 |
| 141 | PLK4 | 0.28468659 |
| 142 | PLK3 | 0.28231361 |
| 143 | MKNK2 | 0.27459847 |
| 144 | ABL2 | 0.27234289 |
| 145 | PDK3 | 0.26723237 |
| 146 | PDK4 | 0.26723237 |
| 147 | LRRK2 | 0.25830341 |
| 148 | FGR | 0.24981246 |
| 149 | CAMKK2 | 0.24947793 |
| 150 | CHEK2 | 0.24680859 |
| 151 | ADRBK1 | 0.24584270 |
| 152 | RPS6KC1 | 0.24579057 |
| 153 | RPS6KL1 | 0.24579057 |
| 154 | MAP2K4 | 0.24539738 |
| 155 | MAPKAPK2 | 0.24428599 |
| 156 | IRAK1 | 0.23675275 |
| 157 | CASK | 0.22360076 |
| 158 | CSF1R | 0.22261186 |
| 159 | BRAF | 0.22109264 |
| 160 | LMTK2 | 0.21342668 |
| 161 | EIF2AK2 | 0.19773901 |
| 162 | DAPK3 | 0.19082464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.64110876 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.97190462 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.47327954 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.30830082 |
| 5 | Bladder cancer_Homo sapiens_hsa05219 | 3.15147459 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.95762863 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.85119683 |
| 8 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.82259763 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81926665 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81692374 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.81517351 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.80830842 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.63829355 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.47744717 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43085704 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.38893774 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.34103480 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29039272 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24149741 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08150900 |
| 21 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.02698420 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.95152095 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.88196802 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87446271 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86577689 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.83876560 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.82599915 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80257170 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.76930269 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75079922 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.67582715 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63131111 |
| 33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.57245523 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.54170803 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50170270 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.49591906 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49008929 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.48407882 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47320722 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.42694094 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.42223508 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.38724985 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36462382 |
| 44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34996600 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.34658388 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34595778 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33086207 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25572080 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22312691 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22305526 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20689996 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18982379 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18012044 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14830980 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12996654 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12731867 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11606220 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08621754 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05793729 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05585346 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05583752 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 1.03885954 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03286797 |
| 64 | Protein export_Homo sapiens_hsa03060 | 1.01556863 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99944519 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98388165 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97178715 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95237599 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94719294 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92523279 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88512310 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.87138972 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84535135 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.81142768 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80592464 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79350032 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78578787 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77032557 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76605391 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75824754 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75157962 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.73789344 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70772693 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69283432 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.69199944 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68448181 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.67769956 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.65846438 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65411195 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64480297 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63276843 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62073460 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61020163 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60134826 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.59718017 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59654435 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59309693 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58244374 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57983137 |
| 100 | DNA replication_Homo sapiens_hsa03030 | 0.57227412 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56878515 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53399617 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51724387 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49941390 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49304525 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48712899 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.47683869 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47240172 |
| 109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45999559 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45652804 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44755622 |
| 112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40346006 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38888488 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37988587 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37935472 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37459651 |
| 117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36760085 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36235370 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35247367 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34613652 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33918715 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32789237 |
| 123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31756504 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30510562 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29999437 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29904568 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27597602 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27170522 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26562696 |
| 130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25189998 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25034486 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23717883 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.20494662 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20324813 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19521527 |
| 136 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.19423898 |
| 137 | Taste transduction_Homo sapiens_hsa04742 | 0.18346876 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.18077771 |
| 139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16651356 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16189548 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.14721395 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.13246453 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12483305 |
| 144 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.12420637 |
| 145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.12364377 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11269370 |
| 147 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.08422342 |
| 148 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08394638 |
| 149 | Cell cycle_Homo sapiens_hsa04110 | 0.08261795 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.06125082 |
| 151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04830249 |

